S. 946 · 119th Congress · Health
MATE Improvement Act
- IntroducedMar 11, 2025 Done
- CommitteeReferred to Health, Education, Labor, and Pensions Current stage
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Became law inside another bill: its text was enacted in H.R. 2483 (SUPPORT for Patients and Communities Reauthorization Act of 2025), signed Dec 1, 2025. The bar shows how far this bill got under its own number.
What it does
This bill expands the types of organizations that may provide required training for practitioners registering with the Drug Enforcement Administration (DEA) to dispense (i.e., prescribe or administer) certain controlled substances.
Current law requires health care practitioners to register with the DEA and complete a one-time training on substance use disorders from specified entities in order to dispense schedule II-V controlled substances. Practitioners who graduated within the last five years from specified types of schools and whose curriculum included similar training on substance use disorders are exempt from having to receive this additional training.
The bill adds several organizations (e.g., the American Academy of Family Physicians) to the list of entities that may provide the required one-time training for physicians or other practitioners. It also expands the types of practitioners who are exempt from this training requirement to include those who graduated from schools of podiatric medicine or schools of pharmacy within the last five years and received similar training as part of their curriculums.
The bill applies retroactively, taking effect as if enacted on December 29, 2022.
Congressional Research Service · summary of “Introduced in Senate” version · Mar 11, 2025
Who lobbies on it
1 organization · 2 filings · Q1 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Biotechnology Innovation Organization
2 of 7 quarters
“FY 2026 Appropriations for Specific Issues ---Drug Pricing ---Antimicrobial Resistance (General) ---Vaccines and Infectious Diseases ---Alternative Funding Programs ---Pandemic Preparedness -R&D Funding for Medical Countermeasures 340B Drug Discount Program ---Executive Order on Access to Affordable Life-Saving…”
Organizations that named S. 946 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.
Actions
2 actions · newest first- Mar 11, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Mar 11, 2025Introduced in Senate